Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6314208 | 1.00 | MAPKAPK2 (1.00) | MAPKAPK2CDK1 | |
| SCHEMBL6311137 | 1.00 | MAPKAPK2 (1.00) | MAPKAPK2CDK1 | |
| SCHEMBL6312607 | 0.90 | MAPKAPK2 (0.82) | MAPKAPK2CDK1 | |
| SCHEMBL6310787 | 0.90 | MAPKAPK2 (0.82) | MAPKAPK2CDK1 | |
| SCHEMBL6320092 | 0.90 | MAPKAPK2 (0.82) | MAPKAPK2CDK1 | |
| SCHEMBL17368534 | 0.87 | MAPKAPK2 (0.77) | MAPKAPK2CDK1 | |
| SCHEMBL6313111 | 0.85 | MAPKAPK2 (0.73) | MAPKAPK2CDK1 | |
| SCHEMBL6311973 | 0.85 | MAPKAPK2 (0.73) | MAPKAPK2CDK1 | |
| SCHEMBL6321017 | 0.85 | MAPKAPK2 (0.73) | MAPKAPK2CDK1 | |
| SCHEMBL17748417 | 0.84 | MAPKAPK2 (1.00) | MAPKAPK2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050250765-A1 | Diazepinones as antiviral agents | CHO HIDETSURA | 2005-11-10 | — | — | US | disclosed |
| US-20040116410-A1 | Diazepinones as antiviral agents | CHO HIDETSURA (JP) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250765-A1 | Diazepinones as antiviral agents | ZC3HAV1, ECI1, ZC3HAV1L | MAPKAPK2 3952/4885CDK1 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.